Using ranibizumab to successfully treat choroidal neovascularization in a patient with persistent placoid maculopathy.
OBJECTIVE
The purpose of this study was to report the successful treatment of persistent placoid maculopathy with intravitreal ranibizumab.


METHODS
A 60-year-old man with an 8-year history of blurry vision was diagnosed with bilateral persistent placoid maculopathy complicated by a choroidal neovascular membrane. The left eye received two laser photocoagulation treatments. The right eye was injected twice with intravitreal bevacizumab and then 3 times with intravitreal ranibizumab over the course of 1 year.


RESULTS
Visual acuity in the left eye dropped from 20/30 to 20/100 despite gradual resolution of fluid. However, visual acuity in the right eye improved from 20/50 to 20/25 where it remained for 24 months after the last injection.


CONCLUSIONS
Ranibizumab seems to be efficacious in the treatment of choroidal neo-vascularization in persistent placoid maculopathy.
From the *New England Eye Center, Tufts Medical Center, Boston, Massachusetts; and †Manhattan Eye and Ear Hospital, New York, New York.
Emily C
EC
Waisbren
Joseph
J
Ho
Lindsay M
LM
Smithen
Lawrence A
LA
Yannuzzi
Jay S
JS
Duker